Skip to main content

Clinical Data Unit to Provide Services to Spacelabs for Heart Studies

NEW YORK (GenomeWeb News) — Clinical Data today said its Cogenics unit will offer its lab services to Spacelabs Healthcare’s clinical trial services branch to help drug makers test for drug-induced QT prolongation.
 
Clinical trial services president Jim Roop said the agreement will allow Spacelabs to offer genetic testing services “into all stages of clinical trials.”
 
Drug-induced QT prolongation commonly slows drug studies because of its link to cardiac difficulties. Clinical Data said that because “several drugs have been pulled from the market as a result of adverse effects related to cardiac safety,” regulators are asking for QT studies before marketing approval.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.